Posted 03 April 2017 - 07:26 PM
I've been taking Vitamin C with my imatinib for a couple of years now and my PCR results have been pretty stable. I noticed these articles are from 2008.
A quote from the researchers: "These results suggest that supplementary vitamin C may have adverse consequences in patients who are receiving cancer chemotherapy. Such a supposition, however, would need confirmation in other therapeutic models or in human trials."
Has there been a human trial or any other confirmation of this research?
Kirk
9/25/2012 p210 transcript 118.7% IS @ Dx, begin Gleevec 400mg/day
12/2012 3.59% & bone marrow biopsy - no residual myeloproliferative features but detected 1/20 metaphases containing the Philadelphia chromosome
2013 0.914%, 0.434%, 0.412%
10/2013 0.360% & bone marrow biopsy - normal male karyotype with no evidence of a clonal cytogenetic abnormaltiy
2014 0.174%, 0.088%, 0.064%
2015 0.049%, decrease to Gleevec 200mg/day, 0.035%, 0.061%, 0.028%
2016 0.041%, 0.039%, 0.025%
2017 0.029%, 0.039%, switched to generic imatinib 200mg/day, 0.070%, 0.088%
2018 0.233%